We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTMX icon
4601
CytomX Therapeutics
CTMX
$753M
$278K ﹤0.01%
15,319
+12,800
+508% +$200K
IMKTA icon
4602
Ingles Markets
IMKTA
$1.67B
$278K ﹤0.01%
10,821
+1,805
+20% +$48.1K
IIN
4603
DELISTED
IntriCon Corporation
IIN
$278K ﹤0.01%
22,987
+7,756
+51% +$70.6K
DUC
4604
DELISTED
Duff & Phelps Utility & Corporate Bond Trust
DUC
$278K ﹤0.01%
30,140
+11,300
+60% +$104K
ARNC.PRB
4605
DELISTED
Arconic Inc.
ARNC.PRB
$278K ﹤0.01%
7,145
+1,613
+29% +$63.7K
LFCR icon
4606
Lifecore Biomedical
LFCR
$190M
$277K ﹤0.01%
21,363
+1,035
+5% +$13.6K
ERIC icon
4607
PUT
Ericsson
ERIC
$33.3B
$276K ﹤0.01%
+48,000
New +$297K
FBSS
4608
DELISTED
Fauquier Bankshares Inc
FBSS
$276K ﹤0.01%
13,900
-14,481
-51% -$270K
CIGI icon
4609
Colliers International
CIGI
$5.19B
$275K ﹤0.01%
5,544
-960
-15% -$50K
KN icon
4610
Knowles
KN
$3.34B
$275K ﹤0.01%
17,977
+7,706
+75% +$118K
WK icon
4611
Workiva
WK
$3.54B
$275K ﹤0.01%
13,177
+1,548
+13% +$30.7K
XPRO icon
4612
Expro Ltd
XPRO
$1.91B
$275K ﹤0.01%
5,928
+3,142
+113% +$141K
DEX
4613
DELISTED
DELAWARE ENHANCED GLOBAL DIVIDEND & INCOME FUND
DEX
$275K ﹤0.01%
23,183
+623
+3% +$7.2K
FGP
4614
DELISTED
Ferrellgas Partners, L.P.
FGP
$275K ﹤0.01%
53,426
-625,591
-92% -$2.99M
AG icon
4615
CALL
First Majestic Silver
AG
$9.07B
$274K ﹤0.01%
40,000
-20,000
-33% -$143K
UMC icon
4616
United Microelectronic
UMC
$46.9B
$274K ﹤0.01%
109,535
+2,740
+3% +$6.71K
DBP icon
4617
Invesco DB Precious Metals Fund
DBP
$255M
$273K ﹤0.01%
7,186
-1,851
-20% -$70.4K
CBH
4618
DELISTED
Virtus Convertible & Income 2024 Target Term Fund
CBH
$273K ﹤0.01%
27,423
+26,833
+4,548% +$269K
AUDC icon
4619
AudioCodes
AUDC
$253M
$272K ﹤0.01%
38,023
+9,863
+35% +$66.3K
ENSG icon
4620
The Ensign Group
ENSG
$10.7B
$272K ﹤0.01%
12,847
+5,746
+81% +$113K
BSX icon
4621
PUT
Boston Scientific
BSX
$71.5B
$271K ﹤0.01%
9,300
+6,800
+272% +$188K
CBF
4622
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
$270K ﹤0.01%
6,564
+4,942
+305% +$189K
JO
4623
DELISTED
iPath Bloomberg Coffee Subindex Total Return ETN due June 24, 2038
JO
$269K ﹤0.01%
16,162
-8,850
-35% -$156K
NFRA icon
4624
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.02B
$268K ﹤0.01%
5,585
+1,870
+50% +$89.5K
VSI
4625
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
$268K ﹤0.01%
+50,000
New +$386K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.